Rheumatoid Arthritis: Biomarkers and the Latest Breakthroughs
International Journal of Molecular Sciences · 30.10.2025 · 26 (21) · 10594
DOI: 10.3390/ijms262110594 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.10.2025. Verfasst von Meilang Xue und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sutton Arthritis Research Laboratory, The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC), Sydney Musculoskeletal Health, Kolling In…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Biomarkers. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CLEARbridge Foundation, Lincoln Centre, Woodend Foundation.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a heterogeneous autoimmune disease characterized by variable clinical manifestations and a complex, often unpredictable disease trajectory, which hinders early diagnosis and personalized treatment. This review highlights recent breakthroughs in biomarker discovery, emphasizing the transformative impact of multi-omics technologies and deep profiling of the synovial microenvironment. Advances in genomics and transcriptomics have identified key genetic variants and expression signatures associated with disease susceptibility, progression, and therapeutic response. Complementary insights from proteomics and metabolomics have elucidated dynamic molecular patterns linked to inflammation and joint destruction. Concurrently, microbiome research has positioned gut microbiota as a compelling source of non-invasive biomarkers with both diagnostic and immunomodulatory relevance. The integration of these diverse data modalities through advanced bioinformatics platforms enables the construction of comprehensive biomarker panels, offering a multidimensional molecular portrait of RA. When coupled with synovial tissue profiling, these approaches facilitate the identification of spatially resolved biomarkers essential for localized disease assessment and precision therapeutics. These innovations are transforming RA care by enabling earlier detection, improved disease monitoring, and personalized treatment strategies that aim to optimize patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sutton Arthritis Research Laboratory, The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC), Sydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney at R…
ORCID-Profile: Meilang Xue
Förderung
- CLEARbridge Foundation
- Lincoln Centre
- Woodend Foundation
Zitieren
APA
Xue, M., Wang, H., Campos, F., Jackson, C. J., & March, L. (2025). Rheumatoid Arthritis: Biomarkers and the Latest Breakthroughs. International Journal of Molecular Sciences, 26(21), 10594. https://doi.org/10.3390/ijms262110594
Vancouver
Xue M, Wang H, Campos F, Jackson CJ, March L. Rheumatoid Arthritis: Biomarkers and the Latest Breakthroughs. International Journal of Molecular Sciences. 2025;26(21):10594. doi:10.3390/ijms262110594
BibTeX
@article{Xue2025,
author = {Xue, Meilang and Wang, Hui and Campos, Frida and Jackson, Christopher J and March, Lyn},
title = {Rheumatoid Arthritis: Biomarkers and the Latest Breakthroughs},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {21},
pages = {10594},
doi = {10.3390/ijms262110594}
}
EUVIMED